These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 15576428)

  • 21. Chemical biology of homocysteine thiolactone and related metabolites.
    Jakubowski H; Głowacki R
    Adv Clin Chem; 2011; 55():81-103. PubMed ID: 22126025
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hydrogen sulfide decreases the plasma lipid peroxidation induced by homocysteine and its thiolactone.
    Olas B; Kontek B
    Mol Cell Biochem; 2015 Jun; 404(1-2):39-43. PubMed ID: 25701360
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Paraoxonase 1 Q192R genotype and activity affect homocysteine thiolactone levels in humans.
    Perła-Kaján J; Borowczyk K; Głowacki R; Nygård O; Jakubowski H
    FASEB J; 2018 May; ():fj201800346R. PubMed ID: 29782204
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determination of homocysteine thiolactone and homocysteine in cell cultures using high-performance liquid chromatography with fluorescence detection.
    Mukai Y; Togawa T; Suzuki T; Ohata K; Tanabe S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Feb; 767(2):263-8. PubMed ID: 11885855
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of homocysteinylation on human high-density lipoproteins: a correlation with paraoxonase activity.
    Ferretti G; Bacchetti T; Marotti E; Curatola G
    Metabolism; 2003 Feb; 52(2):146-51. PubMed ID: 12601623
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Homocysteine editing and growth inhibition in Escherichia coli.
    Sikora M; Jakubowski H
    Microbiology (Reading); 2009 Jun; 155(Pt 6):1858-1865. PubMed ID: 19383686
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Homocysteine thiolactone-induced hyperhomocysteinemia does not alter concentrations of cholesterol and SREBP-2 target gene mRNAS in rats.
    Stangl GI; Weisse K; Dinger C; Hirche F; Brandsch C; Eder K
    Exp Biol Med (Maywood); 2007 Jan; 232(1):81-7. PubMed ID: 17202588
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevention of homocysteine thiolactone induced atherogenesis in rats.
    Kazimir M; Wilson FR
    Res Commun Mol Pathol Pharmacol; 2002; 111(5-6):179-98. PubMed ID: 15244035
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitative assay of plasma homocysteine thiolactone by gas chromatography/mass spectrometry.
    Daneshvar P; Yazdanpanah M; Cuthbert C; Cole DE
    Rapid Commun Mass Spectrom; 2003; 17(4):358-62. PubMed ID: 12569447
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Homocysteine Thiolactone Detoxifying Enzymes and Alzheimer's Disease.
    Jakubowski H
    Int J Mol Sci; 2024 Jul; 25(15):. PubMed ID: 39125665
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantification of homocysteine thiolactone in human saliva and urine by gas chromatography-mass spectrometry.
    Piechocka J; Wrońska M; Chwatko G; Jakubowski H; Głowacki R
    J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Jul; 1149():122155. PubMed ID: 32447254
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The determination of homocysteine-thiolactone in biological samples.
    Jakubowski H
    Anal Biochem; 2002 Sep; 308(1):112-9. PubMed ID: 12234471
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phenolic fractions from Trifolium pallidum and Trifolium scabrum aerial parts in human plasma protect against changes induced by hyperhomocysteinemia in vitro.
    Malinowska J; Kołodziejczyk-Czepas J; Moniuszko-Szajwaj B; Kowalska I; Oleszek W; Stochmal A; Olas B
    Food Chem Toxicol; 2012 Nov; 50(11):4023-7. PubMed ID: 22898612
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of tiopronin on excretion of homocysteine and its plasma exposure level in rats.
    Miyajima A; Bamba M; Onohara T; Hirota T
    Drug Metab Pharmacokinet; 2016 Jun; 31(3):249-51. PubMed ID: 27155909
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative studies on homocysteine and its metabolite-homocysteine thiolactone action in blood platelets in vitro.
    Olas B; Kedzierska M; Wachowicz B
    Platelets; 2008 Nov; 19(7):520-7. PubMed ID: 18979364
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protein homocysteinylation: possible mechanism underlying pathological consequences of elevated homocysteine levels.
    Jakubowski H
    FASEB J; 1999 Dec; 13(15):2277-83. PubMed ID: 10593875
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Paraoxonase 1 protects against protein N-homocysteinylation in humans.
    Perla-Kaján J; Jakubowski H
    FASEB J; 2010 Mar; 24(3):931-6. PubMed ID: 19880629
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protective mechanisms against homocysteine toxicity: the role of bleomycin hydrolase.
    Zimny J; Sikora M; Guranowski A; Jakubowski H
    J Biol Chem; 2006 Aug; 281(32):22485-92. PubMed ID: 16769724
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The disturbance of hemostasis induced by hyperhomocysteinemia; the role of antioxidants.
    Malinowska J; Kolodziejczyk J; Olas B
    Acta Biochim Pol; 2012; 59(2):185-94. PubMed ID: 22577622
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Association of paraoxonase polymorphisms and serum homocysteine thiolactone complex with coronary heart disease].
    Qin Q; Li YL; Zhao FM; Wang H; Li Y; Cui RZ; Zhao BR
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Sep; 34(9):803-7. PubMed ID: 17217688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.